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Objectives. In 2013, Clermont classified E. coli strains into eight phylogenetic groups using a new quadruplex PCRmethod.The aims
of this study were to identify the phylogenetic groups of E. coli based on thismethod and to assess their antibiotic resistance patterns
in Bushehr, Iran.Methods. In this cross-sectional study, 140 E. coli isolates were subjected to phylogenetic typing by a quadruplex
PCR method. Antimicrobial susceptibility testing was performed by disk diffusion method. Results. Phylogenetic group B2 was
most predominant (39.3%), followed by unknown (27.1%), E (9.3%), C and clade I (each 6.4%), B1 (5%), F and D (each 2.9%), and
A (0.7%). The most common antibiotic resistance was related to amoxicillin (82.1%) and the least to meropenem (0.7%). 82.14% of
isolates weremultiple drug resistant (MDR). Antibiotic resistancewasmainly detected in groupB2 (50%).Conclusions.Our findings
showed the high prevalence of MDR E. coli isolates with dominance of group B2. About 25% of E. coli isolates belong to the newly
described phylogroups C, E, F, and clade I. Such studies need to be done also in other regions to provide greater understanding of
the antibiotic resistance pattern and the prevalences of different phylogenetic groups.
1. Introduction
Urinary tract infections (UTIs) are among the most frequent
bacterial infectious diseases, affecting both inpatients and
outpatients around the world [1]. Escherichia coli is one of the
most predominant pathogens, causing 80–90%of all episodes
of UTIs [1–3] and is a troublesome health problem in many
different countries worldwide [4]. The frequency of UTI is
affected by sex and age, with UTI most commonly found in
females of all age groups [2].
Clermont and colleagues developed a triplex PCR assay
to detect the genes chuA, yjaA, and TspE4.C2 in 2000 [5].
Regarding the presence/absence of these three genes, an
E. coli strain could be classified into one of the main
phylogroups, A, B1, B2, or D [5]. The growing body of
multilocus sequence type (MLST) data for E. coli reported
from different hosts and habitats demonstrated that 80 to
85% of the phylogroup classifications are correct. However,
a fraction of strains with special triplex PCR genotypes (A0,
D1, and D2) were incorrectly assigned [6]. In 2013 Clermont
Hindawi Publishing Corporation
BioMed Research International
Volume 2015, Article ID 846219, 7 pages
http://dx.doi.org/10.1155/2015/846219
2 BioMed Research International
and colleagues added an additional gene target, arpA, to those
three candidate markers and made a quadruplex PCR to
classify an E. coli isolate into one of the phylogroups A, B1,
B2, C, D, E, F, and clade I [6].
Worldwide phylogenetic analyses have demonstrated that
virulent extraintestinal E. coli strains belong mainly to group
B2 and, to a lesser extent, to group D. In contrast, most of the
commensal strains are associated with group A or group B1
[1, 2, 7, 8].
Sulfamethoxazole-trimethoprim (cotrimoxazole), fluo-
roquinolones, beta-lactams, nitrofurantoin, and fosfomycin
are the most important antibiotics used in the therapy of UTI
in both community and hospital settings [1, 2]. Currently,
studies clearly show that there is an increasing resistance to
conventional antibiotics among E. coli strains causing UTIs
[9, 10]. Additionally, in recent years the difference in the
antibacterial resistance of E. coli strains of particular phyloge-
netic groups has been considered amatter of importance [11].
Antimicrobial susceptibility surveillance is essential to
evaluate the size of the problem and for the appropriate
selection of antimicrobial drugs for treating infected patients
[9, 10].
To our knowledge this is the first study utilizing the new
quadruplex PCRmethod to categorize phylogenetic groups of
E. coli isolated from patients with UTI in Bushehr, Iran. The
aims of this study were to identify the phylogenetic groups
of E. coli based on new Clermont’s method and to assess the
antimicrobial resistance profile of these strains.
2. Materials and Methods
2.1. Sample Collection. In this cross-sectional study a total
of 6406 urine specimens were collected from patients with
or without clinical symptoms related to urinary tract infec-
tion (UTI), admitted to the Shohadaye Khalije Fars and
17 Shahrivar Hospitals and 5 private clinics (Hakim, Mehr,
Central laboratory, Navid, and Pasteur) in Bushehr, Iran,
in 2013. The European Urinalysis Guidelines have explained
the limit for symptomatic UTI caused by E. coli to be
105 CFU/mL [12]. All the samples were transported to the
Microbiology Laboratory at Bushehr University of Medical
Science for further evaluation under sterile conditions. Also,
demographic data such as age and sex, history of urinary
infection, and history of antibiotic usage were collected. All
steps of this study were approved by the Ethics Committee of
Bushehr University of Medical Science.
2.2. Bacterial Isolates. 140 unique E. coli isolates (obtained
in monoinfection) collected over a period of one year were
selected for this study. All these isolates were cultured on
standardmedia, including blood agar,MacConkey‘s agar, and
Eosin Methylene Blue (Merck, Germany), and were incu-
bated at 37∘C for 24 hours. The isolation and identification of
E. coli strains were performed by routine biochemical tests,
that is, indole, motility, methyl red, Voges-Proskauer, lysine
decarboxylase, Simmon citrate agar, and triple sugar iron
agar (TSI) [13]. In addition, other Gram negative bacteria
were identified by standard biochemical methods [13]. In this
study, a sample of each stored strain was evaluated for purity
on MacConkey agar and kept at −20∘C in skim milk (Merck,
Germany) for long-term storage.
2.3. Antimicrobial Susceptibility Testing. Susceptibility testing
was performed by the Kirby-Bauer disk diffusion method
on Mueller Hinton agar (Merck, Germany) according to
the definition of the Clinical Laboratory Standard Institute
[14]. The antimicrobial drugs used were ampicillin (10 𝜇g),
amikacin (30 𝜇g), amoxicillin (25 𝜇g), ceftizoxime (30 𝜇g),
ceftazidime (30 𝜇g), cephalothin (30 𝜇g), ciprofloxacin (5𝜇g),
cefotaxime (30 𝜇g), ceftriaxone (30 𝜇g), gentamicin (10 𝜇g),
imipenem (10 𝜇g), levofloxacin (5 𝜇g), meropenem (10 𝜇g),
norfloxacin (10 𝜇g), nalidixic acid (30 𝜇g), nitrofurantoin
(300 𝜇g), cotrimoxazole (sulfamethoxazole 23.75 𝜇g + trime-
thoprim 1.75𝜇g), and ofloxacin (5 𝜇g), (Padtan Teb, Tehran,
Iran). E. coli ATCC 25922 and ATCC 35218 were used as the
quality control strains.
2.4. Isolation of Bacterial DNA. DNA for amplification was
extracted from whole cells by the boiling method as follows.
A full loop of pure colonies and overnight cultures was
suspended in 1mL of sterile distilled water. The cells were
lysed by heating at 95∘C for 10 minutes. The supernatant was
harvested by centrifugation at 12,000 rpm for 5 minutes and
kept at −20∘C. The supernatant was used in subsequent PCR
as template DNA [15].
The integrity of extracted DNA was evaluated by elec-
trophoresis on 1% agarose gel. Also, the purity of DNA
was determined by the ratio A260/A280 in a Biophotometer
(Eppendorf, Germany).
2.5. Phylogenetic Analysis. The distribution of phylogenetic
groups amongst E. coli isolates was determined as recently
described by Clermont and colleagues [6]. Briefly, a single
reaction mixture contained 2 𝜇L of 10x buffer (supplied
with Taq polymerase), 2𝜇L of DNA (approximately 100 ng),
20 pmol of each appropriate primer (except for AceK.f
(40 pmol), ArpA1.r (40 pmol), trpBA.f (12 pmol), and trpBA.r
(12 pmol)) (Shanghai Generay Biotech Co., Ltd.), 2mM of
each dNTP, and 2U of Taq DNA polymerase (Fermentas,
Lithuania) in a total volume of 20𝜇L. Primer sequences for
the newphylogroup assignmentmethod are shown in Table 1.
PCR amplifications were carried out on a thermal cycler
Mastercycler gradient (Eppendorf, USA) under the following
conditions: initial denaturation at 94∘C for 4min and 30
cycles for each denaturation at 94∘C for 5 sec, annealing at
57∘C for 20 sec (group E) or 59∘C for 20 sec (quadruplex
and group C), amplification at 72∘C for 1min, and final
extension at 72∘C for 5min [6]. PCR products were analyzed
by electrophoresis with a 2% agarose gel, stained with DNA
safe stain (CinnaGen, Tehran, Iran) and visualized using
GelDoc 2000 transilluminator (Bio-Rad Laboratories,Milan,
Italy). Amolecular weight standard (50 bp ladder, Fermentas,
Lithuania) was included on each gel.
2.6. Statistical Analysis. The data was statistically analyzed
using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). The
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Table 1: Primer sequences used in the extended quadruplex phylotyping method [6].
PCR reaction Primer ID Target Primer sequence PCR product (bp)
Quadruplex
chuA.1b chuA 5-ATGGTACCGGACGAACCAAC-3 288
chuA.2 5-TGCCGCCAGTACCAAAGACA-3
yjaA.1b yjaA 5-CAAACGTGAAGTGTCAGGAG-3 211
yjaA.2b 5-AATGCGTTCCTCAACCTGTG-3
TspE4C2.1b TspE4C2 5-CACTATTCGTAAGGTCATCC-3 152
TspE4C2.2b 5-AGTTTATCGCTGCGGGTCGC-3
AceK.f arpA 5-AACGCTATTCGCCAGCTTGC-3 400
ArpA1.r 5-TCTCCCCATACCGTACGCTA-3
Group E ArpAgpE.f arpA 5-GATTCCATCTTGTCAAAATATGCC-3 301
ArpAgpE.r 5-GAAAAGAAAAAGAATTCCCAAGAG-3
Group C trpAgpC.1 trpA 5-AGTTTTATGCCCAGTGCGAG-3 219
trpAgpC.2 5-TCTGCGCCGGTCACGCCC-3
Internal control trpBA.f trpA 5-CGGCGATAAAGACATCTTCAC-3 489
trpBA.r 5-GCAACGCGGCCTGGCGGAAG-3
AB1CEDFB2Unknown
M M1 2 3 4 5 6 7 8 9 10 11 12 13
500
250
arpA
chuA
yjaA
TspE4C2
Figure 1: Quadruplex PCR profiles of new Clermont phylotyping method. Lane 1, unknown (+ − + +); lane 2, unknown (+ + + +); lane 3,
group B2 (− + + +); lane 4, group B2 (− + + −); lane 5, group F (− + − −); lane 6, group D (+ + − +); lane 7, group D (+ + − −); lane 8, group
E (+ + + −); lane 9, group E (+ + − +); lane 10, group E (+ + − −); lane 11, group C (+ − + −); lane 12, group B1 (+ − − +); lane 13, group A (+
− + −). M: molecular weight marker (50 bp, Fermentas).
chi-square test or the Fisher exact test was applied to compare
categorical variables. 𝑃 values < 0.05 were considered to be
statistically significant.
3. Results
A total of 356 positive urine specimens E. coli strains were
isolated in 140 cases (39.33%) with a count of 105 CFU/mL.
In this study the contribution of other Gram negative bac-
teria was Klebsiella (25.29%), Proteus (12.36%), Pseudomonas
(8.99%), Enterobacter (5.62%), Citrobacter (3.65%), Acineto-
bacter (2.81%), and Moraxella (1.97%), respectively. E. coli
strains were detected more often in females (112/140; 80%)
than in males (28/140; 20%) (𝑃 = 0.001). The participation
of hospital- and community-acquired strains of E. coli was
55.7% (78 cases) and 44.3% (62 cases), respectively. All the
patients with UTI ranged between the ages of 1 and 91 years
and were divided into four specific age groups (e.g., less than
15, 15 to 45, 45 to 60 and more than 60 years). The median
age was 34.39 ± 22.72 years. The age group analysis revealed
that patients younger than 45 years accounted for 70% of the
overall UTI disease, with those between 15 and 45 years of age
being the most affected (50%) (𝑃 = 0.001).
In the present study, the predominant phylogenetic group
was B2 (55/140; 39.3%), followed by unknown (38/140; 27.1%),
E (13/140; 9.3%), C and clade I (9/140; each 6.4%), B1 (7/140;
5%), F and D (4/140; each 2.9%), and A (1/140; 0.7%) (𝑃 =
0.001) (Figure 1). There was no significant difference in the
phylogenetic group composition with regard to age or gender
of the patients.
The disk diffusion method indicated that the E. coli
strains had the highest resistance to amoxicillin (82.1%) and
ampicillin (80%) while resistance to meropenem (0.7%) and
nitrofurantoin (1.4%) was minimal (Table 2).
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Regarding the antibiotic classes it was recognized that
most antibiotic resistance was related to sulfonamides
(57.9%), followed by 𝛽-lactams (48.67%), quinolones
(36.72%), carbapenems (15%), aminoglycosides (12.8%), and
nitrofurans (1.4%), respectively.
In this study 82.14% (115 cases) of isolates were considered
multiple drug resistant (MDR) and 45.71% (64 cases) of the
investigated strains were resistant to at least seven of the
examined antibiotics. Only 12.14% of the strains were sus-
ceptible to all studied antibiotics.
Of these, phylotyping analysis revealed that the most
prevalent multiple drug resistant strain belonged to phy-
logroup B2 (50%) (𝑃 = 0.001). We found significant differ-
ences between phylogenetic groups and resistance to all the
studied antibiotics except nitrofurantoin, amikacin, andmer-
openem.
Group B2 isolates were totally resistant to all studied anti-
biotics except meropenem. Group D isolates were only resist-
ant to four drugs, namely, gentamycin, ampicillin, amoxi-
cillin, and trimethoprim-sulfamethoxazole (Table 2).
4. Discussion
Currently, the clinical management of UTI is a major global
problem because of the increase in infections caused by E.
coli strains that have acquired resistance to commonly used
antimicrobial agents [16]. Studies have indicated that E. coli
antibiotic resistance is mainly related to the phylogenetic
grouping [17].The aim of this study was to identify the phylo-
genetic groups of E. coli based on the new Clermont method
and to assess the relationship between these phylogroups and
antibiotic resistance patterns.
The previous triplex PCR method differentiates all E.
coli strains into four phylogroups, A, B1, B2, and D [5].
Extended phylogenetic analyses have shown that virulent
extraintestinal E. coli strains belonged typically to group B2
and less often to group D [1, 7, 8]. Our findings are in accord-
ance with other studies in Iran [18] and worldwide [11, 19, 20]
where it was found that the majority of isolates of E. coli
predominantly belong to phylogenetic group B2.
In this study, group A had the lowest prevalence. This
result is in contrast to those noted in some previous studies
of extraintestinal E. coli which indicated that most of isolates
belonged to group A [15, 21, 22].
The prevalences of theD andB1 phylogroups found in our
study are much lower than in other countries [3, 19, 22].
These different prevalences of the phylogenetic groups
reported in different studies may be explained by the health
status of the host, dietary and host genetic factors, environ-
mental, social, and geographic conditions, or differences in
sampling areas [15].
The most significant advantage of the new Clermont
quadruplex PCR method for E. coli phylogroup assignment
is its ability to classify strains into groups C, E, F, and clade I.
In the present study, about 25% of E. coli isolates belonged to
these phylogroups. Therefore, this is the first study utilizing
a new quadruplex PCR method for phylotyping of E. coli
in UTI isolates. No data about the prevalences of the newly
described phylogroups in different countries around the
world is available.
Clermont et al. demonstrated that only 1%ofE. coli strains
could not be assigned to one of the eight recognized phy-
logroups using the extended quadruplex method [6]. How-
ever, in the present study more than a quarter (27.1%) of E.
coli isolates of patients with UTI remained unclassified. This
finding is difficult to explain but probably these unassignable
strains are extremely rare phylogroups or are the result of a
recombination between two different phylogroups [6].
In this study, 80% of E. coli strains were resistant to
ampicillin.Thehigh frequency of ampicillin resistance among
E. coli isolates has also been recently reported in variousAsian
and European countries, including Iran [23], China [24],
Switzerland [25], and Italy [26], indicating that treatment
with these agents may be inadequate in many cases.
Recently, trimethoprim-sulfamethoxazole has been con-
sidered as an effective drug in the treatment of UTIs in
many developed and developing countries [27–29]. However,
our results show relatively high resistance rates (57.9%) to
this antibiotic. This high resistance may be attributed to the
possibility of widespread use of this low cost antimicrobial
drug for treatment of UTI in the region.
In the present study, there were high susceptibility rates to
meropenem and nitrofurantoin, indicating that carbapenem
and nitrofuran resistance is still an unusual phenotype among
E. coli isolates. These antibiotics may be considered as good
alternative agents for the treatment of UTI in the region.
This finding was similar to those demonstrated in other
surveillance studies, in which these antibiotics were the most
effective antimicrobial drugs for the treatment of UTI [26, 30,
31]. Resistance to commonly used antimicrobial drugs raises
the global concern about the increased clinical failure rates
and the limited therapeutic options available for physicians
treating UTIs [32].
Our study showed thatmost group B2 isolates were resist-
ant to all studied antibiotics except meropenem.This finding
is in agreement with other studies in Iran [33] and Spain [27]
where it was reported that phylogenetic group B2 is the most
drug resistant.
In addition, all phylogenetic group D isolates were resis-
tant to quinolones. Also, group D isolates were only resistant
to four drugs. In comparison with our results, Bashir et al.
reported that group D was dominant with regard to drug
resistance [34].
In conclusion, our findings showed that group B2 was
themost predominant phylogenetic group andmost resistant
strain to commonly used antibiotics among patients with
UTI. About 25% of E. coli isolates belonged to the newly
described phylogroups C, E, F, and clade I. Studies like
ours need to be done also in other regions to provide
greater understanding of the prevalences and geographic dis-
tribution of E. coli phylogenetic groups.
Regular monitoring of antibiotic resistance patterns will
also help clinicians to prescribe the most appropriate antibi-
otic and to avoid further development of antimicrobial drug
resistance.
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